Stock analysts at StockNews.com initiated coverage on shares of Milestone Scientific (NYSE:MLSS - Get Free Report) in a report released on Monday. The brokerage set a "hold" rating on the stock.
Milestone Scientific Trading Down 7.1 %
Shares of NYSE:MLSS traded down $0.07 during trading on Monday, hitting $0.92. 29,261 shares of the company's stock were exchanged, compared to its average volume of 135,592. The firm has a market cap of $71.66 million, a P/E ratio of -13.14 and a beta of 1.41. The firm has a 50-day moving average price of $1.08 and a two-hundred day moving average price of $0.96. Milestone Scientific has a 1-year low of $0.54 and a 1-year high of $1.39.
Institutional Trading of Milestone Scientific
Institutional investors and hedge funds have recently modified their holdings of the stock. World Investment Advisors LLC acquired a new stake in Milestone Scientific in the third quarter worth $91,000. Renaissance Technologies LLC lifted its holdings in Milestone Scientific by 72.8% during the fourth quarter. Renaissance Technologies LLC now owns 126,275 shares of the company's stock worth $121,000 after acquiring an additional 53,198 shares in the last quarter. Y Intercept Hong Kong Ltd acquired a new position in Milestone Scientific in the third quarter valued at about $48,000. Geode Capital Management LLC raised its position in shares of Milestone Scientific by 6.4% during the third quarter. Geode Capital Management LLC now owns 527,005 shares of the company's stock worth $480,000 after purchasing an additional 31,572 shares during the period. Finally, Carnegie Investment Counsel lifted its holdings in shares of Milestone Scientific by 18.9% during the 4th quarter. Carnegie Investment Counsel now owns 172,609 shares of the company's stock valued at $166,000 after purchasing an additional 27,412 shares in the last quarter. 5.79% of the stock is owned by institutional investors.
Milestone Scientific Company Profile
(
Get Free Report)
Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.
Read More
Before you consider Milestone Scientific, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Milestone Scientific wasn't on the list.
While Milestone Scientific currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
